ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01550367
Recruitment Status : Recruiting
First Posted : March 12, 2012
Last Update Posted : December 23, 2016
Sponsor:
Collaborator:
Prometheus Laboratories
Information provided by (Responsible Party):
Leonard Appleman, University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2018
  Estimated Study Completion Date : March 2018